wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38661390-0FF35350-55FB-42AE-8732-1DFF0DB05828
Q38661390-0FF35350-55FB-42AE-8732-1DFF0DB05828
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38661390-0FF35350-55FB-42AE-8732-1DFF0DB05828
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib.
P2860
Q38661390-0FF35350-55FB-42AE-8732-1DFF0DB05828
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38661390-0FF35350-55FB-42AE-8732-1DFF0DB05828
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
266a5aa1c95e6d67d82c28b54ec45a255cd4ded4
P2860
PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.